Targeting lymphangiogenesis to prevent tumour metastasis
Open Access
- 25 April 2006
- journal article
- review article
- Published by Springer Nature in British Journal of Cancer
- Vol. 94 (10) , 1355-1360
- https://doi.org/10.1038/sj.bjc.6603120
Abstract
Recent studies involving animal models of cancer and clinicopathological analyses of human tumours suggest that the growth of lymphatic vessels (lymphangiogenesis) in or nearby tumours is associated with the metastatic spread of cancer. The best validated molecular signalling system for tumour lymphangiogenesis involves the secreted proteins vascular endothelial growth factor-C (VEGF-C) and VEGF-D that induce growth of lymphatic vessels via activation of VEGF receptor-3 (VEGFR-3) localised on the surface of lymphatic endothelial cells. In this review, we discuss the evidence supporting a role for this signalling system in the spread of cancer and potential approaches for blocking this system to prevent tumour metastasis.Keywords
This publication has 60 references indexed in Scilit:
- Importance of lymph vessels in gastric cancer: a prognostic indicator in general and a predictor for lymph node metastasis in early stage cancerJournal of Clinical Pathology, 2006
- Inhibition of Lymphogenous Metastasis Using Adeno-Associated Virus-Mediated Gene Transfer of a Soluble VEGFR-3 Decoy ReceptorCancer Research, 2005
- Regulation of the stepwise proteolytic cleavage and secretion of PDGF-B by the proprotein convertasesOncogene, 2005
- Augmentation of antitumor effects of p53 Gene therapy by combination with HDAC inhibitorCancer Biology & Therapy, 2005
- Focus on lymphangiogenesis in tumor metastasisCancer Cell, 2005
- Lymphangiogenic growth factors as markers of tumor metastasisAPMIS, 2004
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 2004
- Role of lymphangiogenic factors in tumor metastasisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2004
- Ligand-induced Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) Heterodimerization with VEGFR-2 in Primary Lymphatic Endothelial Cells Regulates Tyrosine Phosphorylation SitesJournal of Biological Chemistry, 2003
- Anti-Cytokine Therapy for Rheumatoid ArthritisAnnual Review of Medicine, 2000